Researchers at academic institutions discover many of the novel insights that advance our understanding of disease. Commercially promising innovations eventually outgrow the lab, requiring greater resources and more focused development expertise than an academic setting can typically provide. To address this need, Deerfield has pioneered a model of partnership through research collaborations, which creates the potential for rapid funding and advancement of promising therapies.
Deerfield Discovery and Development (3DC) plays a critical role in progressing early-stage therapeutics from scientific discovery through preclinical proof of concept and into the clinic, via design and execution of relevant experiments. 3DC partners closely with principal investigators in Deerfield’s academic collaboration network, corporate partners and entrepreneurs to provide deep functional expertise and experience across key disciplines. These include:
- Genetic Assessment and Insights
- Chemistry
- In Vitro Pharmacology
- Translational Biology
- Drug Metabolism and Pharmacokinetics
- Safety Assessment
- Chemistry, Manufacturing, and Controls (CMC)
- Clinical & Regulatory
- Project Management